{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:55:09Z","timestamp":1790981709818,"version":"4.1.0"},"reference-count":27,"publisher":"Georg Thieme Verlag KG","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Monbl Augenheilkd"],"DOI":"10.1055\/a-2641-1346","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:39:11Z","timestamp":1790980751000},"source":"Crossref","is-referenced-by-count":0,"title":["Therapie des Trockenen Auges \u2013 aktuelle Empfehlungen nach DEWS-III-Report"],"prefix":"10.1055","author":[{"given":"Christina","family":"Jacobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ajo.2025.05.039","article-title":"TFOS DEWS III: Management and Therapy","volume":"279","author":"L Jones","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ajo.2025.05.033","article-title":"TFOS DEWS III: Diagnostic Methodology","volume":"279","author":"JS Wolffsohn","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ajo.2025.09.035","article-title":"TFOS DEWS III: Executive Summary","volume":"282","author":"VL Perez","year":"2026","journal-title":"Am J Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ajo.2025.05.040","article-title":"TFOS DEWS III: Digest","volume":"279","author":"F Stapleton","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II Diagnostic Methodology Report","volume":"15","author":"JS Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/ICL.0000000000000258","article-title":"Compliance and Subjective Patient Responses to Eyelid Hygiene","volume":"43","author":"YA Alghamdi","year":"2017","journal-title":"Eye Contact Lens"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00347-004-1101-6","article-title":"[Gas permeable scleral lenses as a conservative treatment option for\n\t\t\t\t\textreme corneal ectasis and severe dry eye]","volume":"102","author":"KT Hanisch","year":"2005","journal-title":"Ophthalmologe"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jfo.2011.07.017","article-title":"Efficacy of 0,18% hypotonic sodium hyaluronate ophthalmic solution in the\n\t\t\t\t\ttreatment of signs and symptoms of dry eye disease","volume":"35","author":"V Baeyens","year":"2012","journal-title":"J Fr Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4103\/IJO.IJO_2666_22","article-title":"Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild\n\t\t\t\t\tto moderate dry eye disease","volume":"30","author":"JH Lee","year":"2011","journal-title":"Cornea"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1097\/ICO.0b013e318180e55c","article-title":"Effect of hypotonic 0,4% hyaluronic acid drops in dry eye patients: a\n\t\t\t\t\tcrossover study","volume":"27","author":"P Troiano","year":"2008","journal-title":"Cornea"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/aos.15159","article-title":"Hyaluronic acid in the treatment of dry eye disease","volume":"100","author":"L Hynnekleiv","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.3390\/ijerph18052383","article-title":"A meta-analysis of the efficacy of hyaluronic acid eye drops for the\n\t\t\t\t\ttreatment of dry eye syndrome","volume":"18","author":"Y Yang","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1089\/jop.2012.0066","article-title":"Prospective, randomized, controlled comparison of SYSTANE UD eye drops\n\t\t\t\t\tversus VISINE INTENSIV 1% EDO eye drops for the treatment of moderate dry\n\t\t\t\t\teye","volume":"28","author":"C Jacobi","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1097\/ICO.0b013e31821de383","article-title":"Tear film osmolarity measurements in dry eye disease using electrical\n\t\t\t\t\timpedance technology","volume":"30","author":"C Jacobi","year":"2011","journal-title":"Cornea"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1097\/ICO.0000000000000273","article-title":"Six-month effects of a thermodynamic treatment for MGD and implications of\n\t\t\t\t\tmeibomian gland atrophy","volume":"33","author":"D Finis","year":"2014","journal-title":"Cornea"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/OPX.0000000000001354","article-title":"The effect of microblepharon exfoliation on clinical correlates of contact\n\t\t\t\t\tlens discomfort","volume":"96","author":"JS Siddiredy","year":"2019","journal-title":"Optom Vis Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1167\/iovs.14-15764","article-title":"Prospective trial of intense pulsed light for the treatment of meibomian\n\t\t\t\t\tgland dysfunction","volume":"56","author":"JP Craig","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"993","DOI":"10.2147\/OPTH.S213664","article-title":"Combined low level light therapy and intense pulsed light therapy for the\n\t\t\t\t\ttreatment of meibomian gland dysfunction","volume":"13","author":"K Stonecipher","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1055\/a-1115-4756","article-title":"Wenn Tr\u00e4nenersatzmittel nicht mehr ausreichen: die Bedeutung von\n\t\t\t\t\tEntz\u00fcndungsprozessen beim Trockenen Auge. Praktische Aspekte einer\n\t\t\t\t\tantientz\u00fcndlichen Therapie des Trockenen Auges [If Artificial Tears Aren\u2019t\n\t\t\t\t\tEnough. The Importance of Inflammatory Processes in Dry Eye Disease. Practical\n\t\t\t\t\tAspects of an Anti-Inflammatory Therapy of Dry Eye Disease]","volume":"237","author":"U Pleyer","year":"2020","journal-title":"Klin Monbl Augenheilkd"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/ICO.0000000000000803","article-title":"Safety of lifitegrast ophthalmic solution 5.0% in patients with dry eye\n\t\t\t\t\tdisease: A 1-year, multicenter, randomized, placebo-controlled study","volume":"35","author":"ED Donnenfeld","year":"2016","journal-title":"Cornea"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e8213","DOI":"10.5867\/medwave.2021.05.8213","article-title":"Autologous serum compared to artificial tear drops for dry eye\n\t\t\t\t\tdisease","volume":"21","author":"F Manzur Yarur","year":"2021","journal-title":"Medwave"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s40265-015-0409-7","article-title":"Diquafosol ophthalmic solution 3%: a review of its use in dry\n\t\t\t\t\teye","volume":"75","author":"GM Keating","year":"2015","journal-title":"Drugs"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ophtha.2016.09.023","article-title":"A randomized, double-masked, placebo-controlled clinical trial of two\n\t\t\t\t\tforms of omega-3 supplements for treating dry eye disease","volume":"124","author":"LA Deinema","year":"2017","journal-title":"Ophthalmology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1056\/NEJMoa1709691","article-title":"n-3 fatty acid supplementation for the treatment of dry eye\n\t\t\t\t\tdisease","volume":"378","author":"PA Asbell","year":"2018","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/jamaophthalmol.2013.195","article-title":"Topical interleukin 1 receptor antagonist for treatment of dry eye\n\t\t\t\t\tdisease: a randomized clinical trial","volume":"131","author":"F Amparo","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1097\/ICO.0000000000002554","article-title":"Treatment of dry eye from laser-assisted in situ keratomileusis with\n\t\t\t\t\trecombinant human nerve growth factor (Cenegermin)","volume":"40","author":"RN Habibi","year":"2021","journal-title":"Cornea"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.3390\/pharmaceutics14091859","article-title":"Transient receptor potential channels: Important players in ocular pain\n\t\t\t\t\tand dry eye disease","volume":"14","author":"D Fakih","year":"2022","journal-title":"Pharmaceutics"}],"container-title":["Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2641-1346.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:39:11Z","timestamp":1790980751000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2641-1346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":27,"URL":"https:\/\/doi.org\/10.1055\/a-2641-1346","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0023-2165","1439-3999"],"issn-type":[{"value":"0023-2165","type":"print"},{"value":"1439-3999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]}}}